Dalian Free Trade Zone will build "Gene Cell Therapy Pilot Zone"

        On April 19, the Dalian Free Trade Zone and Dalian Medical University signed a framework agreement to jointly build the "Dalian Gene Cell Therapy Pilot Demonstration Zone" in the Dalian Free Trade Zone. The two parties will give full play to their respective advantages in policies, talents, technology, resources, etc., focus on cutting-edge fields such as gene cell therapy, and focus on solving industry common problems and "stuck neck" technical problems, and jointly create an internationally renowned and domestically leading highland in the pharmaceutical and life and health industries . Member of the Standing Committee of the Municipal Party Committee, Secretary of the Party Working Committee of Jinpu New Area, Director of the Management Committee, Li Pengyu, Secretary of the Party Committee of Dalian Free Trade Area, Sun Zhaolin, Secretary of the Party Committee of Dalian Medical University, Zhao Jie, Vice President of Dalian Medical University, Liu Aimin, Director of the Management Committee of Dalian Free Trade Area, etc. Attend the signing ceremony.
        According to the agreement, the two parties will build a cell therapy clinical medical center to promote cell therapy in the Dalian Free Trade Zone. Give full play to the advantages of Dalian Medical University's disciplines, high-level talents and high-level medical care, and focus on in-depth research in the fields of cell therapy, genetic testing, and drug research and development. Explore the establishment of a research and development and achievement transformation model adapted to the characteristics of the Dalian Free Trade Area, strive to realize the transformation and application of key core technologies in the area, and actively carry out foreign cooperation in gene cell therapy. Build a gene public service platform to provide technical support and personnel training for normalized epidemic prevention and control, and traceability of pathogenic microorganism genetic testing of frozen commodities and imported commodities.
        Liu Aimin, Director of the Management Committee of the Dalian Free Trade Zone, said in his speech that the Dalian Free Trade Zone attaches great importance to the development of the large health industry represented by gene cell therapy and regards it as an important direction for regional industrial transformation and upgrading. Cooperating with Dalian Medical University to build a whole industry chain of cells, genes, and medical care has opened up a new model of medical, research, and enterprise integration, which will surely promote related industries to reach new heights and make the Northeast Asia Industrial Demonstration Zone more international.
        Zhao Jie, Vice President of Dalian Medical University, introduced the fruitful achievements the school has made in the cutting-edge fields of regenerative medicine, gene technology, and precision medicine in recent years. At the same time, he spoke highly of the courage, efficiency and enthusiasm shown by the Dalian Free Trade Zone in the course of cooperation, and was full of confidence in future cooperation. He said that Dalian Medical University will fully support the construction of the "Pioneer Demonstration Zone" and, together with the Dalian Free Trade Zone, rely on their respective superior resources, focus on platform construction, and strive to create a new highland for the transformation and application of scientific and technological achievements.
        It is understood that gene cell therapy is currently one of the key development directions of the biomedical industry. In recent years, my country's scientific research investment in the field of gene cell therapy has increased year by year, and its technical strength has continued to increase. The number of new clinical studies every year is second only to the United States and has become one of the most active countries in the world for cell therapy clinical research. The Dalian Free Trade Zone and Dalian Medical University jointly established the "Dalian Gene Cell Therapy Pilot Demonstration Zone", which is an important measure to seize opportunities in the big health industry, promote regional industrial upgrading, and advance technological innovation and development. The area will take this as an opportunity to fully release the national "experimental field" policy dividends, create good conditions for Dalian Medical University to carry out cutting-edge medical technology research and industrial innovation, and focus on building drugs including drug development, medical and health care, life and health big data, etc. The stem cell application industry chain is fully empowered to promote industrial innovation and is a pioneer in building a healthy China.